Study of the functional effects of nusinersen in adult spinal amyotrophic individuals due to 5q type 2 or 3 genetic deficiency: single-case experimental study with multiple baselines across subjects, multicenter, randomized, single-blind
Latest Information Update: 01 Jan 2024
At a glance
- Drugs Nusinersen (Primary)
- Indications Spinal muscular atrophy
- Focus Therapeutic Use
Most Recent Events
- 01 Jan 2024 New trial record